knowledge -WSS

knowledge

author：leisure time 2025-09-07 14:07:14 - browse：3

Medicare and money photo illustration. — Adobe

Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services. In a letter sent to the agency and shared with STAT, the group urged CMS to act on finalizing a pathway that would make reimbursement for breakthrough devices easier.

CMS has been working on implementing the pathway since 2021. A CMS spokesperson told STAT the agency is working “expeditiously” to finalize it. Scott Whitaker, CEO of AdvaMed, said the device industry is tired of waiting.

“I myself have begun to wonder if they’re really serious about doing this, or if they’re just saying they’re serious about doing it for political reasons or otherwise,” Whitaker told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Can U.S. cancer drug shortages be fixed?

leisure time

WSS

Why Talkspace is targeting Medicare, a tricky market

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Former Pear Therapeutics executives start new VC firm

How to make over

FDA greenlights medical device to combat bladder issues

California store owner shot dead in dispute over displaying Pride flag: Police

hotspot

knowledge

hotspot

How one medical school became remarkably diverse

Medicare drug price negotiation hearing pits pharma v Biden admin

How to save PrEP access — and even expand it

Ancient Greek ideas underpin modern concepts of pregnancy

Sports medicine is finally prioritizing gender equality

Families look for replacement for GSK asthma drug Flovent

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare drug price negotiation continues, as pharma counteroffers

Guidelines to prevent youth baseball injuries need more muscle

CDC says it’s too soon to assess risk posed by Covid subvariant

focus

Stem cell biologist probes earliest stages of human development

How the drug

Longer MASH drug regimen improved liver, Akero study finds

A new approach to psychiatric drug development

Pregnant women don't need prenatal multivitamins, study concludes

The public health thinking behind the CDC’s new Covid guidance

hotspot

leisure time

focus

entertainment